This non-binding ACE2-Fc variant was created by substituting 8 amino acids engaged in the interaction between human ACE2 and the RBD of the SARS-CoV-2 spike protein with their mouse ACE2 counterparts, because wild-type mice were found to be resistant to infection by early SARS-CoV-2 variants39. The gene discussed is ACE2; the disease is infection.